vascular endothelial growth factor receptor 2 (VEGFR2) is an important therapeutic target for angiogenesis-related disorders such as proliferative diabetic retinopathy and neovascular age-related macular degeneration [220]. Here, KDR is linked to proliferative diabetic retinopathy.